JT-010

JT-010
Names
	Preferred IUPAC name 2-Chloro-N-[4-(4-methoxyphenyl)-1,3-thiazol-2-yl]-N-(3-methoxypropyl)acetamide
Identifiers
CAS Number	917562-33-5;
3D model (JSmol)	Interactive image;
ChemSpider	17834320;
PubChem CID	18524489;
CompTox Dashboard (EPA)	DTXSID401336571 ;
	InChI InChI=1S/C16H19ClN2O3S/c1-21-9-3-8-19(15(20)10-17)16-18-14(11-23-16)12-4-6-13(22-2)7-5-12/h4-7,11H,3,8-10H2,1-2H3 Key: KZMAWJRXKGLWGS-UHFFFAOYSA-N;
	SMILES O=C(N(C1=NC(C2=CC=C(OC)C=C2)=CS1)CCCOC)CCl;
Properties
Chemical formula	C16H19ClN2O3S
Molar mass	354.85 g·mol−1
	Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). Infobox references

JT-010 is a chemical compound which acts as a potent, selective activator of the TRPA1 channel, and has been used to study the role of this receptor in the perception of pain, as well as other actions such as promoting repair of dental tissue after damage.^[1]^[2]^[3]^[4]

References

^ Takaya J, Mio K, Shiraishi T, Kurokawa T, Otsuka S, Mori Y, Uesugi M (December 2015). "A Potent and Site-Selective Agonist of TRPA1". Journal of the American Chemical Society. 137 (50): 15859–64. Bibcode:2015JAChS.13715859T. doi:10.1021/jacs.5b10162. hdl:2433/215437. PMID 26630251.
^ Heber S, Gold-Binder M, Ciotu CI, Witek M, Ninidze N, Kress HG, Fischer MJ (May 2019). "A Human TRPA1-Specific Pain Model". The Journal of Neuroscience. 39 (20): 3845–3855. doi:10.1523/JNEUROSCI.3048-18.2019. PMC 6520506. PMID 30862667.
^ Suo Y, Wang Z, Zubcevic L, Hsu AL, He Q, Borgnia MJ, et al. (March 2020). "Structural Insights into Electrophile Irritant Sensing by the Human TRPA1 Channel". Neuron. 105 (5): 882–894.e5. doi:10.1016/j.neuron.2019.11.023. PMC 7205012. PMID 31866091.
^ Tazawa K, Kawashima N, Kuramoto M, Noda S, Fujii M, Nara K, et al. (September 2020). "Transient Receptor Potential Ankyrin 1 Is Up-Regulated in Response to Lipopolysaccharide via P38/Mitogen-Activated Protein Kinase in Dental Pulp Cells and Promotes Mineralization". The American Journal of Pathology. 190 (12): 2417–2426. doi:10.1016/j.ajpath.2020.08.016. PMID 32919979. S2CID 221674768.

[1] Takaya J, Mio K, Shiraishi T, Kurokawa T, Otsuka S, Mori Y, Uesugi M (December 2015). "A Potent and Site-Selective Agonist of TRPA1". Journal of the American Chemical Society. 137 (50): 15859–64. Bibcode:2015JAChS.13715859T. doi:10.1021/jacs.5b10162. hdl:2433/215437. PMID 26630251.

[2] Heber S, Gold-Binder M, Ciotu CI, Witek M, Ninidze N, Kress HG, Fischer MJ (May 2019). "A Human TRPA1-Specific Pain Model". The Journal of Neuroscience. 39 (20): 3845–3855. doi:10.1523/JNEUROSCI.3048-18.2019. PMC 6520506. PMID 30862667.

[3] Suo Y, Wang Z, Zubcevic L, Hsu AL, He Q, Borgnia MJ, et al. (March 2020). "Structural Insights into Electrophile Irritant Sensing by the Human TRPA1 Channel". Neuron. 105 (5): 882–894.e5. doi:10.1016/j.neuron.2019.11.023. PMC 7205012. PMID 31866091.

[4] Tazawa K, Kawashima N, Kuramoto M, Noda S, Fujii M, Nara K, et al. (September 2020). "Transient Receptor Potential Ankyrin 1 Is Up-Regulated in Response to Lipopolysaccharide via P38/Mitogen-Activated Protein Kinase in Dental Pulp Cells and Promotes Mineralization". The American Journal of Pathology. 190 (12): 2417–2426. doi:10.1016/j.ajpath.2020.08.016. PMID 32919979. S2CID 221674768.

[1]

[2]

[3]

[4]

See also

References